Patents by Inventor Kamini Mendis

Kamini Mendis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1
    Publication number: 20100291133
    Abstract: The invention relates to a recombinant protein fabricated in a baculovirus system, of which the essential constitutive polypeptide sequence is that of a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite of the Plasmodium type, particularly Plasmodium falciparum, which is infectious for humans, said C-terminal fragment remaining normally anchored at the surface of the parasite at the end of its penetration phase into human erythrocytes, in the occurrence of an infectious cycle. Said recombinant protein is applicable to the production of vaccines against malaria.
    Type: Application
    Filed: December 28, 2009
    Publication date: November 18, 2010
    Applicants: INSTITUT PASTEUR, NEW YORK UNIVERSITY
    Inventors: SHIRLEY LONGACRE-ANDRE, CHARLES ROTH, FARIDABANO NATO, JOHN W. BARNWELL, KAMINI MENDIS
  • Recombinant protein containing a C-terminal fragment of MSP-1
    Patent number: 7696308
    Abstract: The invention relates to a recombinant protein fabricated in a baculovirus system, of which the essential constitutive polypeptide sequence is that of a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite of the Plasmodium type, particularly Plasmodium falciparum, which is infectious for humans, said C-terminal fragment remaining normally anchored at the surface of the parasite at the end of its penetration phase into human erythrocytes, in the occurrence of an infectious cycle. Said recombinant protein is applicable to the production of vaccines against malaria.
    Type: Grant
    Filed: June 6, 2005
    Date of Patent: April 13, 2010
    Assignees: Institut Pasteur, New York University
    Inventors: Shirley Longacre-Andre, Charles Roth, Faridabano Nato, John W. Barnwell, Kamini Mendis
  • Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1
    Publication number: 20070036818
    Abstract: The present invention provides a recombinant protein comprising a 19 kDa C-terminal fragment of the surface protein 1 of the merozoite form of a Plasmodium type parasite other than Plasmodium vivax which is infectious in man.
    Type: Application
    Filed: June 29, 2006
    Publication date: February 15, 2007
    Applicants: INSTITUT PASTEUR, NEW YORK UNIVERSITY
    Inventors: Shirley Longacre-Andre, Charles Roth, Faridabano Nato, John Barnwell, Kamini Mendis
  • Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1
    Publication number: 20060018932
    Abstract: The invention relates to a recombinant protein fabricated in a baculovirus system, of which the essential constitutive polypeptide sequence is that of a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite of the Plasmodium type, particularly Plasmodium falciparum, which is infectious for humans, said C-terminal fragment remaining normally anchored at the surface of the parasite at the end of its penetration phase into human erythrocytes, in the occurrence of an infectious cycle. Said recombinant protein is applicable to the production of vaccines against malaria.
    Type: Application
    Filed: June 6, 2005
    Publication date: January 26, 2006
    Applicants: INSTITUT PASTEUR, NEW YORK UNIVERSITY
    Inventors: Shirley Longacre-Andre, Charles Roth, Faridabano Nato, John Barnwell, Kamini Mendis
  • Recombinant protein containing a C-terminal fragment of plasmodium MSP-1
    Patent number: 6958235
    Abstract: The invention relates to a recombinant protein fabricated in a baculovirus system, of which the essential constitutive polypeptide sequence is that of a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite of the Plasmodium type, particularly Plasmodium falciparum, which is infectious for humans, said C-terminal fragment remaining normally anchored at the surface of the parasite at the end of its penetration phase into human erythrocytes, in the occurrence of an infectious cycle. Said recombinant protein is applicable to the production of vaccines against malaria.
    Type: Grant
    Filed: February 14, 1997
    Date of Patent: October 25, 2005
    Assignees: Institute Pasteur, New York University
    Inventors: Shirley Longacre-Andre, Charles Roth, Faridabano Nato, John W. Barnwell, Kamini Mendis
  • RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1
    Publication number: 20020076403
    Abstract: The invention relates to a recombinant protein fabricated in a baculovirus system, of which the essential constitutive polypeptide sequence is that of a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite of the Plasmodium type, particularly Plasmodium falciparum, which is infectious for humans, said C-terminal fragment remaining normally anchored at the surface of the parasite at the end of its penetration phase into human erythrocytes in the occurrence of an infectious cycle. Said recombinant protein is applicable to the production of vaccines against malaria.
    Type: Application
    Filed: August 14, 1998
    Publication date: June 20, 2002
    Inventors: SHIRLEY LONGACRE-ANDRE, CHARLES ROTH, FARIDABANO NATO, JOHN W. BARNWELL, KAMINI MENDIS